Officer Daniel Lippis Files to Sell $261K in Edwards Lifesciences Stock
Edwards Lifesciences Corp
Subscribe to track EW
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Officer Daniel Lippis Files to Sell $261K in Edwards Lifesciences Stock
Company: Edwards Lifesciences Corp (EW) Form: 144 | Filed: 2026/03/11 Significance: Low
Insider: Daniel J. Lippis Title: Officer | Relationship: Officer
Transaction: • Type: Proposed Sale • Shares: 3,057 • Price: ~$85.38 (est) • Value: $261,013 • Plan: 10b5-1 (Adopted 07/30/2025)
Key Insight: Routine cashless exercise of options via a pre-arranged 10b5-1 trading plan. Transaction value is negligible relative to market cap.
Market Context: Transaction represents <0.001% of the $47.4B market cap. No material impact expected.
Comprehensive Analysis
SEC Filing Analysis: Edwards Lifesciences Corp (EW)
Executive Summary
- Trading Significance: Low
- Key Takeaway: Officer executes a routine cashless option exercise and sale under a 10b5-1 plan.
- Market Impact: Neutral - transaction size is immaterial to the stock price.
Company Information
| Field | Value |
|---|---|
| Company | Edwards Lifesciences Corp |
| CIK | 0001099800 |
| Industry | Orthopedic, Prosthetic & Surgical Appliances |
Insider Information
| Field | Value |
|---|---|
| Name | Daniel J. Lippis |
| CIK | 0002004380 |
| Title/Position | Officer |
| Relationship | Officer |
Transaction Details
| Field | Value |
|---|---|
| Form Type | 144 (Notice of Proposed Sale) |
| Transaction Date | 2026/03/11 |
| Transaction Code | S (Proposed) |
| Security Type | Common Stock |
| Shares Involved | 3,057 |
| Price Per Share | ~$85.38 (Calculated) |
| Total Value | $261,013.00 |
| Nature of Payment | Broker Payment for Cashless Exercise |
Financial Impact Assessment
Transaction Materiality
| Metric | Value |
|---|---|
| Transaction Value | $261,013 |
| % of Market Cap | 0.0006% |
| Shares Transacted | 3,057 |
| % of Shares Outstanding | 0.0005% |
| Materiality Assessment | Low |
Impact Evaluation
- Market Cap Context: With a market cap of $47.42 billion, a $261k transaction is statistically irrelevant.
- Dilution Impact: The shares originate from an employee stock option exercise. While technically dilutive, 3,057 shares against 580.8 million outstanding represents negligible dilution (0.0005%).
- Transaction Significance: The sale is conducted under a Rule 10b5-1 trading plan adopted on July 30, 2025, indicating this was a scheduled liquidity event rather than a reaction to current market conditions.
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: The transaction volume is too small to affect the share price, and the use of a 10b5-1 plan removes negative sentiment regarding insider confidence.
Volume & Sentiment
- Expected Volume Impact: None.
- Sentiment Indicator: Neutral.
Additional Context
Transaction Notes
- Special Circumstances: The filing notes "Broker Payment for Cashless Exercise," suggesting the insider is selling shares to cover the cost of exercising options and related taxes.
- Prior Sales: The insider sold similar small blocks (1,019 shares) in Dec 2025 and Jan 2026, consistent with a structured divestment plan.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.